Clear Street launches healthcare equity research, to debut at JP Morgan Healthcare conference
Financial technology and capital markets firm Clear Street launched its healthcare and biotechnology equity research last month...
Sell side Archive
Why liquidity deserves a spot on every issuer’s to-do list
When it comes to capital markets, liquidity is the quiet hero everyone needs but rarely talks about. Sure, fundamentals are king...
A Swedish guide to ‘analyst massaging’: how to balance storytelling and information provision
Now and then, claims are made that public companies have said or implied information in closed rooms that affected the perception...
Why Puig Brands' post-IPO performance shows confidence must take precedence over the stock price
The greatest asset for any listed company is investor confidence. It is the fundamental pillar that encourages fund managers to...
Read more
Short-seller Citron Capital charged with fraud
What are the main crises an IR team might need to handle? Profit warnings, unexpected leadership changes and major operational...
Read more
Taking the Shein off: Human rights group petitions against London IPO
There’s been a dramatic political shift in the UK: Rishi Sunak’s Conservative Party took huge losses in last week’s general...
Crafting clarity in investor relations
For investor relations professionals, consistent communication and strategic messaging are essential. This isn’t merely an...
Read more
Global IPO market shows signs of recovery in run up to 2024
Easing inflation and possible interest rate cuts may revive global IPO activity in 2024, attracting investors with improved...
Read more
How to get the most out of sell-side engagement
A perennial IR challenge is how to prioritize your time and focus across your company’s sell-side followers. That remains the case...
Don’t believe the hype: Fundamentals and long-term investment potential still rule the day
As analyst coverage options shrink for small-cap and micro-cap companies and the UBS-Credit Suisse combination points to further...
